AusPAR: Xembify

Australian Public Assessment Report

AusPAR

AusPAR: Xembify [PDF, 700.42 KB]

AusPAR: Xembify [Word, 546.21 KB]

AusPAR Attachment 1: Product Information for Xembify [PDF, 183.96 KB]

AusPAR Attachment 1: Product Information for Xembify [Word, 80.39 KB]

Device/Product Name

Xembify

Active ingredients

Normal immunoglobulin (Human)

AusPAR Date

23 January 2023

Published

30 January 2023

Submission Number

PM-2020-06238-1-2

Submission Type

New biological entity

Decision

Approved